US$ 28.96
wada prohibited list bpc-157 tb-500 status 2025 published Athlete Advisory: Explanation of Key
Description
Safety is always our top priority

reconstituted forms, transit-time math, and the practice that actually matters

No marketing authorization exists for therapeutic human use: BPC-157 remains strictly a peptide for exploratory research

Its ~5day halflife enables convenient onceweekly administration [1]

This also prevents accidental disconnection of the needle
